Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
141 participants
INTERVENTIONAL
2000-10-31
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abatacept
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Huntsville, Alabama, United States
Local Institution
La Jolla, California, United States
Local Institution
Long Beach, California, United States
Local Institution
Los Angeles, California, United States
Local Institution
Palo Alto, California, United States
Local Institution
San Francisco, California, United States
Local Institution
Denver, Colorado, United States
Local Institution
Fort Lauderdale, Florida, United States
Local Institution
Titusville, Florida, United States
Local Institution
Rome, Georgia, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Hagerstown, Maryland, United States
Local Institution
Boston, Massachusetts, United States
Local Institution
Springfield, Massachusetts, United States
Local Institution
Duluth, Minnesota, United States
Local Institution
Lincoln, Nebraska, United States
Local Institution
New Brunswick, New Jersey, United States
Local Institution
Los Alamos, New Mexico, United States
Local Institution
Albany, New York, United States
Local Institution
Mineola, New York, United States
Local Institution
New York, New York, United States
Local Institution
Bismarck, North Dakota, United States
Local Institution
Cincinnati, Ohio, United States
Local Institution
Portland, Oregon, United States
Local Institution
Duncansville, Pennsylvania, United States
Local Institution
Norristown, Pennsylvania, United States
Local Institution
Charleston, South Carolina, United States
Local Institution
Knoxville, Tennessee, United States
Local Institution
Austin, Texas, United States
Local Institution
Dallas, Texas, United States
Local Institution
Temple, Texas, United States
Local Institution
Salt Lake City, Utah, United States
Local Institution
Edmonds, Washington, United States
Local Institution
Tacoma, Washington, United States
Local Institution
Glendale, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IM101-101
Identifier Type: -
Identifier Source: org_study_id